title: A Paradigm Shift on the Question of B Cells in Transplantation? Recent Insights on Regulating the Alloresponse.
abstract: B lymphocytes contribute to acute and chronic allograft rejection through their production of donor-specific antibodies (DSAs). In addition, B cells present allopeptides bound to self-MHC class II molecules and provide costimulation signals to T cells, which are essential to their activation and differentiation into memory T cells. On the other hand, both in laboratory rodents and patients, the concept of effector T cell regulation by B cells is gaining traction in the field of transplantation. Specifically, clinical trials using anti-CD20 monoclonal antibodies to deplete B cells and reverse DSA had a deleterious effect on rates of acute cellular rejection; a peculiar finding that calls into question a central paradigm in transplantation. Additional work in humans has characterized IL-10-producing B cells (IgM memory and transitional B cells), which suppress the proliferation and inflammatory cytokine productions of effector T cellsin vitro. Understanding the mechanisms of regulating the alloresponse is critical if we are to achieve operational tolerance across transplantation. This review will focus on recent evidence in murine and human transplantation with respect to non-traditional roles for B cells in determining clinical outcomes.
authors.affiliation: Transplant Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Firl
authors.affiliation: Transplant Center, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.
authors.forename: Gilles
authors.initials: G
authors.lastname: Benichou
authors.affiliation: Transplant Center, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.
authors.forename: James I
authors.initials: JI
authors.lastname: Kim
authors.affiliation: Transplant Center, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.
authors.forename: Heidi
authors.initials: H
authors.lastname: Yeh
keywords: allorecognition; antigen presentation; autoimmune diseases; regulatory B cells; transplant rejection; transplant tolerance